HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson's disease.

Abstract
Ethanol extract (GP-EX) of Gynostemma pentaphyllum (GP) ameliorates chronic stress-induced anxiety in mice. The present study investigated the effects of gypenoside-enriched components (GPS), GP-EX and water extract of GP (GP-WX) on MPTP lesion-induced affective disorders in C57BL/6 mice. GPS (50mg/kg) and GP-EX (50mg/kg) for 21 day-treatment period improved the symptom of anxiety disorders in the MPTP-lesioned mouse model of PD with or without L-DOPA treatment, which was examined by the elevated plus-maze and marble burying tests. In these states, treatments with GPS (50mg/kg) and GP-EX (50mg/kg) significantly increased the brain levels of dopamine and serotonin in the MPTP-lesioned mouse model of PD with or without l-DOPA treatment. In addition, treatments with GPS (50mg/kg) and GP-EX (50mg/kg) showed protective effects on dopaminergic neurons in MPTP-lesioned mouse model of PD with or without L-DOPA treatment. In contrast, GPS (30 mg/kg) and GP-WX (50mg/kg) showed anxiolytic effects in the same animal models, but it was not significant. These results suggest that GPS (50mg/kg) and GP-EX (50mg/kg) showed anxiolytic effects on affective disorders and protective effects on dopaminergic neurons by modulating the brain levels of dopamine and serotonin in the MPTP-lesioned mouse model of PD with or without l-DOPA treatment. Clinical trials of GPS and GP-EX need to be conducted further so as to develop adjuvant therapeutic agents for PD patients.
AuthorsKeon Sung Shin, Ting Ting Zhao, Hyun Sook Choi, Bang Yeon Hwang, Chong Kil Lee, Myung Koo Lee
JournalBrain research (Brain Res) Vol. 1567 Pg. 57-65 (Jun 03 2014) ISSN: 1872-6240 [Electronic] Netherlands
PMID24747613 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Anxiety Agents
  • Antiparkinson Agents
  • Neuroprotective Agents
  • Plant Extracts
  • gypenoside
  • Water
  • Serotonin
  • Ethanol
  • Levodopa
  • Dopamine
Topics
  • Animals
  • Anti-Anxiety Agents (pharmacology)
  • Antiparkinson Agents (pharmacology)
  • Anxiety Disorders (drug therapy, etiology, pathology, physiopathology)
  • Behavior, Animal (drug effects)
  • Brain (drug effects, pathology, physiopathology)
  • Dopamine (metabolism)
  • Dopaminergic Neurons (drug effects, pathology, physiology)
  • Ethanol (chemistry)
  • Gynostemma
  • Levodopa (pharmacology)
  • Male
  • Maze Learning (drug effects)
  • Mice, Inbred C57BL
  • Neuroprotective Agents (pharmacology)
  • Neuropsychological Tests
  • Parkinsonian Disorders (complications, drug therapy, pathology, physiopathology)
  • Phytotherapy
  • Plant Extracts (isolation & purification, pharmacology)
  • Serotonin (metabolism)
  • Water (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: